Global Health Screening Market, By Test Type (Cholesterol Tests, Diabetes Test, Cancer Screening, General Check Up Test, STDs, Blood Pressure Test, Others), Package Type (Basic Health Screening, Senior Citizen Profile, Women Health Check, Men Health Check, Heart Check, Diabetes Check, Others), Panel Type (Multi-Test Panels, Single-Test Panels), Sample Type (Blood, Urine, Serum, Saliva, Others), Technology (Immunoassays, Medical Imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis), Others), Condition (Cardiovascular Disease, Metabolic Disorders, Cancer, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions, Others), Sample Collection Sites (Hospital, Homes, Diagnostic Laboratories, Offices, Others), Distribution Channel (Direct Tenders, Retail Sales, Others) - Industry Trends and Forecast to 2031.
Health Screening Market Analysis and Insights
The market for health screening is estimated to increase rapidly over the forecast period. According to a study conducted by the University of Utah GSLC, researchers were able to achieve telomerase activity inhibition in prostate and breast cancer cells cultivated in the lab, resulting in tumor cell death. As a result of these studies, telomere test kits in cellular health screening and other applications have increased, which is projected to boost the health screening market in the forecast years. Hence, an increase in the frequency of chronic diseases and an increase in the geriatric population has resulted in a high demand for health screening in the market.
Data Bridge Market Research analyses that the global health screening market, which was USD 2,91,272.4 million in 2023, is likely to reach USD 8,23,374.65million by 2031 and is expected to undergo a CAGR of 12.5% during the forecast period. “Hospitals” dominate the end-user segment of the market due to the rise in the aging population. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Health Screening Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016-2021) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Test Type (Cholesterol Tests, Diabetes Test, Cancer Screening, General Check Up Test, STDs, Blood Pressure Test, Others), Package Type (Basic Health Screening, Senior Citizen Profile, Women Health Check, Men Health Check, Heart Check, Diabetes Check, Others), Panel Type (Multi-Test Panels, Single-Test Panels), Sample Type (Blood, Urine, Serum, Saliva, Others), Technology (Immunoassays, Medical Imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis), Others), Condition (Cardiovascular Disease, Metabolic Disorders, Cancer, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions, Others), Sample Collection Sites (Hospital, Homes, Diagnostic Laboratories, Offices, Others), Distribution Channel (Direct Tenders, Retail Sales, Others) |
|
Countries Covered |
U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa |
|
Market Players Covered |
Quest Diagnostics Incorporated (U.S.), GRAIL(U.S.), Eurofins Scientific (Luxembourg), Exact Sciences Corporation (U.S.), SYNLAB International GmbH (Germany), UNILABS (Switzerland), LabPLUS (U.S.), BioReference Laboratories (U.S.), Sonic Healthcare Limited (Australia), ACM Global Laboratories (NY), Cerba Healthcare (France), Quidel Corporation (U.S.), Innova Medical Group (U.S.), Amedes Holding GmbH (Germany), RadNet, Inc. (U.S.), Natera, Inc. (U.S.), Trinity Biotech (Ireland), Nuffield Health (UK), RepeatDx (Canada), NeoGenomics Laboratories (U.S.), H.U Group Holdings, Inc. (Japan), ARUP Laboratories (U.S.), Q2 Solutions (U.S.), Genova Diagnostics (U.S.) |
|
Market Opportunities |
|
Market Definition
Health screening is an important tool for detecting a disease early on. Screening tests are frequently used in preventative medicine to determine whether a person displays early indicators of a condition's risk factors. Cancer, diabetes, high cholesterol, high blood pressure, and osteoporosis are all diseases that can be discovered by screening.
Global Health Screening Market Dynamics
Drivers
- Increasing prevalence of chronic diseases
The rising prevalence of chronic diseases such as diabetes, high blood pressure, cancer, high cholesterol, and osteoporosis will propel the market’s growth rate.
- Rise in the number of geriatric population
The number of persons aged 60 and up has consistently increased over time as a result of rising life expectancy. The rising awareness about early detection and treatment of disease will be a major factor influencing the growth of the health screening market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the health screening market. Also, increasing expenditure on healthcare infrastructure and the continuously changing lifestyle of people are the major market drivers that will further escalate the growth of health screening market.
Opportunity
- Technological advancement
The rising adoption rate of advanced technologies will provide beneficial opportunities for the health screening market growth. Moreover, growing number of service providers and increase in the number of emerging markets will further provide beneficial opportunities for the health screening market growth during the forecast period.
Restraint/Challenge
- High cost associated with screening test
The high cost associated with screening test will further obstruct the growth rate of health screening market. On the other hand, the dearth of skilled professionals and technical limitations will challenge the health screening market.
This health screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the health screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In November 2021, Evoq Technologies LLC had announced the launch of first smartphone-based product for retinal health testing. The "SmartERG" Platform is designed to assess the retinal health of the eye in novel ways. With the force multipliers of simple patient-provider connection, cloud-based analytical services, and a great fit for artificial intelligence, the SmartERG Platform will offer a breakthrough delivery approach for ophthalmic patient care
- In September 2021, Eurofins Scientific SE’s subsidiary Transplant Genomics had announced the launch of OmniGraf. It combines the Viracor TRAC donor-derived cell-free DNA assays with the TruGraf blood gene expression test. OmniGraf Kidney is the first diagnostic tool for renal transplant recipients that integrates cell-free DNA and gene expression data. When paired with TGI's unique technology and machine learning, the test provides patients with the most accurate and timely assessment of kidney transplant rejection
Global Health Screening Market Scope
The health screening market is segmented on the basis of test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Cholesterol Tests
- Diabetes Test
- Cancer Screening
- General Check Up Test
- STDs
- Blood Pressure Test
- Others
Package Type
- Basic Health Screening
- Senior Citizen Profile
- Women Health Check
- Men Health Check
- Heart Check
- Diabetes Check
- Others
Panel Type
- Multi-Test Panels
- Single-Test Panels
Sample Type
- Blood
- Urine
- Serum
- Saliva
- Others
Technology
- Immunoassays
- Medical Imaging
- QPCR (Quantitative Polymerase Chain Reaction)
- Q-FISH (Quantitative Fluorescence, in Situ Hybridization)
- TRF (Terminal Restriction Fragment)
- STELA (Single Telomere Length Analysis)
- Others
Condition
- Cardiovascular Disease
- Metabolic Disorders
- Cancer
- Inflammatory Conditions
- Musculoskeletal Disorders
- Neurological Conditions
- Hepatitis-C Complications
- Immunology-Related Conditions
- Others
Sample Collection Sites
- Hospital
- Homes
- Diagnostic Laboratories
- Offices
- Others
Distribution Channel
- Direct Tenders
- Retail Sales
- Others
Health Screening Market Regional Analysis/Insights
The health screening market is analyzed and market size insights and trends are provided by country, test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel as referenced above.
The countries covered in the market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Kuwait, Egypt, and rest of Middle East & Africa.
North America is expected to dominate the market due to the presence of a well-established healthcare sector and development of advanced technology in this region. In addition, growing presence of major market players will flourish the market’s growth rate in this region.
Asia-Pacific is expected to show fastest growth during the forecast period due to the rising prevalence of chronic diseases and the increasing number of geriatric populations in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The health screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for health screening market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the health screening market. The data is available for historic period 2010-2020.
New Product Launches by Manufacturers is Creating New Opportunities for Players in the Global Health Screening Market
The Health Screening market also provides you with detailed market analysis for every country growth in aesthetic industry with Health Screening market sales, impact of advancement in the Health Screening market and changes in regulatory scenarios with their support for the Health Screening market. The data is available for historic period 2012 to 2021.
Competitive Landscape and Global Health Screening Market Share Analysis
The health screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to health screening market.
Some of the major players operating in the health screening market are:
- Quest Diagnostics Incorporated (U.S.)
- GRAIL(U.S.)
- Eurofins Scientific (Luxembourg)
- Exact Sciences Corporation (U.S.)
- SYNLAB International GmbH (Germany)
- UNILABS (Switzerland)
- LabPLUS (U.S.)
- BioReference Laboratories (U.S.)
- Sonic Healthcare Limited (Australia)
- ACM Global Laboratories (NY)
- Cerba Healthcare (France)
- Quidel Corporation (U.S.)
- Innova Medical Group (U.S.)
- Amedes Holding GmbH (Germany)
- RadNet, Inc. (U.S.)
- Natera, Inc. (U.S.)
- Trinity Biotech (Ireland)
- Nuffield Health (UK)
- RepeatDx (Canada)
- NeoGenomics Laboratories (U.S.)
- H.U Group Holdings, Inc. (Japan)
- ARUP Laboratories (U.S.)
- Q2 Solutions (U.S.)
- Genova Diagnostics (U.S.)
SKU-
